Ardelyx, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ARDX on Nasdaq
Industry
Pharmaceutical Preparations
Location
34175 Ardenwood Blvd., Fremont, California

Insiders trading volume in the past year

Ardelyx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Scott D. Sandell 10%+ Owner $15M Dec 9, 2021
Forest Baskett 10%+ Owner $15M Dec 9, 2021
David M. Mott Director $8.04M Jun 14, 2024
Michael Raab President & CEO, Director $7.59M -$1.53M -16.8% Aug 27, 2024
Susan Rodriguez Chief Commercial Officer $3.51M -$134K -3.67% May 21, 2024
David Rosenbaum Chief Development Officer $3.43M -$1.18M -25.6% Aug 20, 2024
Robert Blanks Chief Regulatory and Quality Affairs Officer $1.87M -$350K -15.7% Aug 20, 2024
Laura A. Williams Chief Medical Officer $1.84M -$1.6M -46.5% Aug 20, 2024
Justin Renz Chief Financial Officer $1.73M -$1.56M -47.4% Aug 20, 2024
Richard J. Rodgers Director $1.67M Jun 14, 2024
William Bertrand Director $1.53M Jun 14, 2024
Mike Kelliher Executive Vice President, Corporate Development and Strategy $1.24M Mar 25, 2024
Elizabeth Grammer Chief Legal and Administrative Officer $1.13M -$3.99M -78% Aug 20, 2024
Eric D. Foster Chief Commercial Officer $1.03M Aug 8, 2024
Jan M. Lundberg Director $975K Jun 15, 2023
Jeffrey W. Jacobs Chief Scientific Officer $793K Nov 22, 2021
Robert Ora Felsch SVP Finance and Chief Accounting Officer $537K -$1.9M -78% Aug 20, 2024
Geoffrey A. Block Director Jun 15, 2023
Muna Bhanji Director Jun 14, 2024
Onaiza Cadoret-Manier Director Jun 14, 2024
Robert B. Bazemore Director Jun 14, 2024

Recent Insider Transactions by Companies or Individuals for Ardelyx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.